Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Repligen (RGEN)

Add to Watchlists
Create an Alert
15.66 -0.18  -1.14% NASDAQ Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
RGEN Price Chart
View All Events

RGEN Events

Date Type Description
Mar 06 Earnings Repligen Corporation Q4 2013 Earning Result.
Mar 06 Misc Repligen Corporation Q4 2013 Earning Conference Call
Nov 07 Misc Repligen to Report Third Quarter 2013 Financial Conference Call
Nov 07 Earnings Repligen to Report Third Quarter 2013 Financial Results.
Aug 01 Misc Q2 2013 Repligen Corporation Earnings Conference Call
Aug 01 Earnings Repligen to Report Second Quarter 2013 Financial Results.
May 09 Misc AGM Event for Repligen Corp.
May 02 Misc Repligen to Report First Quarter 2013 Financial Results Conference Call
May 02 Earnings Repligen to Report First Quarter 2013 Financial Results. Estimate: 999.00.
View All Performance Charts

RGEN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Repligen is up 72.47% over the last year vs S&P 500 Total Return up 21.54%, Targacept down 1.62%, and Aegerion Pharmaceuticals up 11.49%.

Get Quote for

Portfolio Strategies Featuring RGEN

Did Repligen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

RGEN Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Repligen Corporation is a life sciences company engaged in the development, manufacture & sale of consumable bioprocessing products for life sciences companies & biopharmaceutical manufacturing companies worldwide. It also supplies growth factor products.

Recent Quotes

Symbol Price Chg Chg % Market Cap
RGEN 15.66 -0.18 -1.14% 500.11M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.